The Bidirectional Relationship Between Body Mass Index and Treatment Outcome in Adolescents with Treatment-Resistant Depression
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Depression and obesity are associated, but the impact of obesity on depression treatment outcome, or, conversely, the impact of treatment on body mass index (BMI) in depressed adolescents has not been reported. In this article, we examine the bidirectional relationships between BMI and treatment response in adolescents with treatment-resistant depression. METHOD: Participants in the Treatment of Selective Serotonin Reuptake Inhibitor (SSRI) Resistant Depression in Adolescents (TORDIA) study had height and weight assessed at baseline, weekly for the first 6 weeks, biweekly for the next 6 weeks, and monthly from weeks 12 through 24. The impact of baseline BMI as a predictor and moderator of treatment response was assessed. In addition, participants' changes in BMI were assessed as a function of specific treatment assignment and treatment response. RESULTS: Participants assigned to SSRIs had a greater increase in BMI-for-age-sex z-score and weight than did those assigned to venlafaxine. Post-hoc, those treated with paroxetine or citalopram had the biggest increases in BMI, relative to fluoxetine or venlafaxine. Overweight or obesity was neither a predictor nor a moderator of treatment outcome, nor of subsequent BMI change. CONCLUSIONS: Overweight status does not appear to affect treatment response in adolescents with resistant depression. The successful treatment of depression does not appear to favorably affect weight or BMI. Fluoxetine and venlafaxine are less likely to cause an increase in BMI than paroxetine or citalopram.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M. P., & Marks, J. S. (1998) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00017-8 · Cited by 18,943
BIRMAHER, B., KHETARPAL, S., BRENT, D., CULLY, M., BALACH, L., KAUFMAN, J., & NEER, S. M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00018 · Cited by 2,846 · cited 4×
“1988); SCARED, Self-Report for Childhood Anxiety Related Disorders (Birmaher et al. 1997); BHS, Beck Hopelessness Scale (Beck et al.”
MethodInfluentialSelf-citationECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
Keller, M. B. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180050009 · Cited by 1,643
Nanni, V., Uher, R., & Danese, A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020335 · Cited by 1,480
Association between obesity and psychiatric disorders in the US adult population
Simon, G. E., Von Korff, M., Saunders, K., Miglioretti, D. L., Crane, P. K., van Belle, G., & Kessler, R. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.824 · Cited by 1,338
Major depressive disorder in older adolescents
Lewinsohn, P. M., Rohde, P., & Seeley, J. R. (1998) · Clinical Psychology Review · doi:10.1016/s0272-7358(98)00010-5 · Cited by 1,078 · cited 2×
“2010;), and up to 1 in 5 adolescents will have experienced at least one major depressive episode by age 18 (Lewinsohn et al. 1998).”
BackgroundEpidemiology and treatment of depression in patients with chronic medical illness
J. Katon, W. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/wkaton · Cited by 820 · cited 1×
“It may be that depression may moderate the response to a weight reduction intervention, but as none was routinely offered in this study, we cannot comment on that possibility (Katon 2011).”
KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00010 · Cited by 641 · cited 1×
“Remarkably, none of the other child and adolescent clinical trials of the treatment of depression reported actual weight changes (Emslie et al. 1997; Keller et al. 2001; March et al. 2004; Emslie et al. 2006; Wagner et al. 2006).”
BackgroundSelf-citationAntidepressants and Body Weight: A Comprehensive Review and Meta-Analysis
Serretti, A., & Mandelli, L. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05346blu · Cited by 621 · cited 2×
“The association of paroxetine with weight gain is well established in the adult literature, although there is also evidence of an association of weight gain with the use of other antidepressants as well (Fava et al. 2000; Patten et al. 2009; Serretti and Mandelli 2010).”
BackgroundMeyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517 · cited 1×
“However, the absence of an association between BMI and medication treatment outcome in our sample may also be explained by the broad range of drug concentration values associated with an acceptable level of serotonin transport binding and treatment response (Meyer et al. 2004; Sakolsky et al. 2011).”
BackgroundRimer, J., Dwan, K., Lawlor, D. A., Greig, C. A., McMurdo, M., Morley, W., & Mead, G. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub5 · Cited by 330
Reynolds, W. M., & Mazza, J. J. (1999) · School Psychology Review · doi:10.1080/02796015.1999.12085945 · Cited by 300 · cited 3×
“1974), Suicidal Ideation Questionnaire–Junior High School version (SIQ-Jr) (Reynolds and Mazza 1999), and the Screen for Anxiety Related Disorders (SCARED) (Birmaher et al.”
BackgroundMethodTreatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes
Emslie, G. J., Mayes, T., Porta, G., Vitiello, B., Clarke, G., Wagner, K. D., Asarnow, J. R., Spirito, A., Birmaher, B., Ryan, N., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09040552 · Cited by 217 · cited 2×
“…and results of treatment efficacy, as well as predictors and moderators of response, in the Treatment of Resistant Depression in Adolescence (TORDIA) study at 12 and 24 weeks, have been reported in detail in previous publications (Brent et al. 2008; Asarnow et al. 2009; Emslie et al. 2010).”
BackgroundResultSelf-citationEmslie, G. J., Ventura, D., Korotzer, A., & Tourkodimitris, S. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181a2b304 · Cited by 210 · cited 1×
“In an acute study of escitalopram, Emslie et al. (2009) found that both those on drug and on placebo gained on average 0.55 kg, whereas in an acute trial of sertraline in depressed children and adolescents, those treated with sertraline lost 0.23 kg, whereas those treated with placebo gained 0.78…”
ResultInfluentialSelf-citationOverweight and Obesity Affect Treatment Response in Major Depression
Kloiber, S., Ising, M., Reppermund, S., Horstmann, S., Dose, T., Majer, M., Zihl, J., Pfister, H., Unschuld, P. G., Holsboer, F., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.001 · Cited by 208 · cited 2×
“In the Munich Antidepressant Response Study (MARS), higher BMI was associated with a slower clinical response as well as a lower likelihood of normalization in tests of attention and of cortisol dynamics (Kloiber et al. 2007).”
BackgroundResultDaley, A. J., Copeland, R. J., Wright, N. P., Roalfe, A., & Wales, J. K. H. (2006) · Pediatrics · doi:10.1542/peds.2006-1285 · Cited by 170
Hamer, M., Batty, G. D., & Kivimaki, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.30 · Cited by 132 · cited 2×
“…risk for depression, possibly mediated by body shape dissatisfaction, peer or parental teasing, and decreased self-esteem, or because of incipient metabolic syndrome (Young-Hyman et al. 2006; Libbey et al. 2008; Wang et al. 2009; Bang et al. 2012; Hamer et al. 2012; SanchezVillegas et al. 2013).”
BackgroundPetty, K. H., Davis, C. L., Tkacz, J., Young-Hyman, D., & Waller, J. L. (2009) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsp007 · Cited by 110 · cited 1×
“Clinical trials in overweight and obese adolescents have shown that aerobic exercise, in addition to contributing to weight loss, also reduces depressive symptomatology, even in those with clinically significant depressive self-reported symptoms (Daley et al. 2006; Petty et al. 2009).”
BackgroundGariepy, G., Wang, J., Lesage, A. D., & Schmitz, N. (2010) · Obesity · doi:10.1038/oby.2009.333 · Cited by 70 · cited 1×
“However, some longitudinal studies do not find that obesity predicts future depression (Gariepy et al. 2010).”
BackgroundNilsson, M., Joliat, M. J., Miner, C. M., Brown, E. B., & Heiligenstein, J. H. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.412 · Cited by 40 · cited 2×
“Consistent with our findings, Nilsson et al. (2004) found relatively little change in weight on those treated with fluoxetine, with a smaller increase in both weight and height than in those treated with placebo: Height (fluoxetine, 1.0 cm [SD = 2.4] vs. placebo, 2.1 cm [SD = 2.6]; p = 0.004) and…”
BackgroundResultInfluential
Cited by
Goldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., Stoney, C. M., Wasiak, H., & McCrindle, B. W. (2015) · Circulation · doi:10.1161/cir.0000000000000229 · Cited by 519
“with greater increases in diastolic blood pressure than treatment with SSRIs (n=168).(234) The same study found an ≈2-kg increase in weight for venlafaxine-treated youth and ≈3-kg increase in”
BackgroundWoo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79
“In contrast to the above results, a study of adolescent TRD subjects [61] did not support different effects of BMI on treatment response to different antidepressant classes.”
ResultCourtney, D. B., Watson, P., Krause, K. R., Chan, B. W. C., Bennett, K., Gunlicks-Stoessel, M., Rodak, T., Neprily, K., Zentner, T., & Szatmari, P. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.46331 · Cited by 63
Dimitrova, T. D., Reeves, G. M., Snitker, S., Lapidus, M., Sleemi, A. R., Balis, T. G., Manalai, P., Tariq, M. M., Cabassa, J. A., Karim, N. N., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.038 · Cited by 16
Metadata
- Authors
- Mansoor, B., Rengasamy, M., Hilton, R., Porta, G., He, J., Spirito, A., Emslie, G. J., Mayes, T. L., Clarke, G., Wagner, K. D., Shamseddeen, W., Birmaher, B., Ryan, N., & Brent, D.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-09
- Volume
- 23
- Issue
- 7
- Pages
- 458-467
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2028842872
- Cited by
- 34
- References
- 22
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.